Discover 3,556 paid clinical trials in Santa Ana, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,556
Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)
for
Sickle Cell Disease
Location: Orange CA, Little Rock AR, Flowood MS, Atlanta GA,
Sponsor: CSL Behring
Sex: All
Age: 18+
Code: NCT07224360
Phase2, Recruiting
Descartes-08 in Autoantibody Myositis
for
Antisynthetase Syndrome
Location: Orange CA, Austin TX, Chapel Hill NC, Boston MA
Sponsor: Cartesian Therapeutics
Sex: All
Age: 18+
Code: NCT07391605
Phase2, Recruiting
A Study to Learn About How 20-Valent Pneumococcal Conjugate Vaccine Works in a Real-world Setting
for
Pneumonia
Location: Ontario CA, Riverside CA, Pasadena CA, Fontana CA,
Sponsor: Pfizer
Sex: All
Age: 65+
Code: NCT05452941
Recruiting
Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer
for
Kidney Cancer
Location: Los Angeles CA, Portland OR, Maywood IL, Nashville TN,
Sponsor: Jonsson Comprehensive Cancer Center
Sex: All
Age: 18+
Code: NCT00301990
Phase2, Recruiting
A Study to Test How Well Different Doses of BI 764532 Are Tolerated by People With a Tumour in the Brain That is Positive for DLL3
for
Glioma
Location: Orange CA, Nashville TN
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT05916313
Phase1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)
for
Generalized Myasthenia Gravis
Location: Orange CA, Los Angeles CA, Scottsdale AZ,
Sponsor: Vor Biopharma
Sex: All
Age: 18+
Code: NCT06456580
Phase3, Recruiting
Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Bowel
for
Bowel; Stricture
Location: Irvine CA, Los Angeles CA, Lancaster CA, San Diego CA,
Sponsor: GIE Medical
Sex: All
Age: 22+
Code: NCT05561127
Phase3, Recruiting
Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
for
Metastatic Small Intestinal Adenocarcinoma,
Location: Anaheim CA, Irvine CA, Bellflower CA, Baldwin Park CA,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT04205968
Phase2, Recruiting
A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations
for
NSCLC (Advanced Non-small Cell Lung Cancer)
Location: Irvine CA, La Jolla CA, Phoenix AZ, Stanford CA,
Sponsor: BlossomHill Therapeutics
Sex: All
Age: 18+
Code: NCT06706076
Phase1, Phase2, Recruiting
Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma
for
Carcinoma, Renal Cell
Location: Orange CA, Palo Alto CA, San Francisco CA, Houston TX,
Sponsor: Oncorena AB
Sex: All
Age: 18+
Code: NCT05287945
Phase1, Phase2, Recruiting
Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage
for
Intracerebral Hemorrhage, Stroke, Hypertension
Location: Irvine CA, Lancaster CA, Palo Alto CA, San Antonio TX,
Sponsor: Zeenat Qureshi Stroke Institute
Sex: All
Age: 18 - 70+
Code: NCT06402968
Recruiting
NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
for
Major Depressive Disorder
Location: Redlands CA, Huntsville AL, Glendale CA,
Sponsor: Neurocrine Biosciences
Sex: All
Age: 18+
Code: NCT06911112
Phase3, Recruiting
Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer
for
Intermediate Risk Non-Muscle Invasive Bladder Cancer
Location: Orange CA, Los Angeles CA, Santa Monica CA, Murrieta CA,
Sponsor: Ferring Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06510374
Phase3, Recruiting
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
for
Head and Neck Squamous Cell Carcinoma (HNSCC),
Location: Los Angeles CA, Houston TX, Grand Rapids MI,
Sponsor: Tanabe Pharma America, Inc.
Sex: All
Age: 18+
Code: NCT06943521
Phase1, Phase2, Recruiting
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer